YOKO MOMOYAMA: Open Payments
NPI 1801863253 · LOMBARD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 11 payments from 5 companies in 2025. Trend: 2023 $277 · 2024 $1,615 · 2025 $426
Food & beverage: $336Travel & lodging: $90
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $178 |
| AstraZeneca Pharmaceuticals LP | 3 | $146 |
| ABBVIE INC. | 3 | $57 |
| PFIZER INC. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
Products named: Wegovy, VRAYLAR, Ozempic, Rybelsus, NURTEC ODT, JARDIANCE.
Industry payments across IL — which companies pay providers there.
